Results 1 to 10 of about 3,229,409 (289)

Obesity, type 2 diabetes and hormone replacement therapy vs. colorectal tumors in the elderly

open access: yesJournal of Education, Health and Sport, 2017
Aims. A prophylaxis program for the early detection of colorectal cancer carried out by our department since the year 2000 has been extended to include people aged 65 and older. The subjects were asked additional questions regarding their dietary habits
Małgorzata Szamocka   +4 more
doaj   +3 more sources

Cardiovascular risk in hormone replacement therapy

open access: yesBleeding, Thrombosis and Vascular Biology
Hormone replacement therapy (HRT) effectively alleviates vasomotor symptoms related to menopause, but it can also raise the risk of cardiovascular disease. Several factors influence the likelihood of developing coronary artery disease or ischemic stroke,
Doris Barcellona
doaj   +1 more source

Prevention and treatment of venous thromboembolism during HRT: current perspectives

open access: yesInternational Journal of General Medicine, 2014
Hannelore Rott Coagulation Center Rhine-Ruhr, Duisburg, Germany Abstract: Many large trials in the past 15 years have proven an increased risk of vascular complications in women using oral, mostly non-bioidentical, hormone therapy.
Rott H
doaj  

HORMONE REPLACEMENT THERAPY AND PREVENTION OF THROMBOTIC COMPLICATIONS

open access: yesАкушерство, гинекология и репродукция, 2016
Pathogenesis of thrombotic complication caused by hormone replacement therapy and influence of HRT on risk of venous and arterial thrombosis are reviewed.
A. V. Vorob'ev   +2 more
doaj  

Fezolinetant - a potential alternative to hormone replacement therapy for menopausal women

open access: yesJournal of the Pakistan Medical Association
Dear Editor, Menopause is a significant milestone in a woman's life, marking the end of the reproductive cycle due to the depletion of all the ovarian follicles.
Hassan Mehmood   +2 more
doaj   +1 more source

HORMONE REPLACEMENT THERAPY AND VENOUS THROMBOEMBOLISM

open access: yesZdravniški Vestnik, 2008
BACKGROUND Oral hormone replacement therapy (HRT) is associated with 2- to 4-fold increased riskof venous thromboembolism (VTE). Therefore, all women commencing HRT should becounselled about the risk of VTE, signs and symptoms of VTE and measures for ...
Nina Vene
doaj  

Changes in the profile of lipoprotein subfractions associated with hormone replacement therapy

open access: yesArquivos Brasileiros de Cardiologia, 2001
OBJECTIVE: To report the effects of 2 regimens of hormone replacement therapy during the postmenopausal period on the profile of the major lipoprotein subfractions (HDL, LDL, and VLDL). METHODS: We carried out a cohort study in 38 postmenopausal patients
José Luiz da Costa Vieira   +3 more
doaj   +1 more source

Hormone Replacement Therapy: An Update [PDF]

open access: yesThe Journal of Obstetrics and Gynecology of India, 2012
Ever since menopause was causally linked to several symptoms and disease processes, the concept of hormone replacement therapy (HRT) took root and was widely practiced over half a century. We have witnessed the rise and fall of the HRT during these years.
openaire   +2 more sources

Remarkable change in age-specific breast cancer incidence in the Swiss canton of Geneva and its possible relation with the use of hormone replacement therapy

open access: yesBMC Cancer, 2006
Background This article aims to explain the reasons for the remarkable change in age of breast cancer occurrence in the Swiss canton of Geneva. Methods We used population-based data from the Geneva cancer registry, which collects information on method of
Wespi Yves   +5 more
doaj   +1 more source

HYPOGONADOTROPIC HYPOGONADISM (REVIEW)

open access: yesПедиатрическая фармакология, 2008
The review is dedicated to the problem of hypogonadotropic hypogonadism. Modern ideas of the stages of normal sexual development of girls, etiology and pathogenesis of constitutional arrest of sexual development and hypogonadotropic hypogonadism are ...
E.V. Uvarova, E.V. Trifonova
doaj   +2 more sources

Home - About - Disclaimer - Privacy